Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice ; day:26 ; month:7 ; year:2024 ; pages:1-9
European journal of nuclear medicine and molecular imaging ; (26.7.2024), 1-9
- Urheber
-
Burvenich, Ingrid Julienne Georgette
Osellame, Laura Danielle
Rigopoulos, Angela
Huynh, Nhi
Cao, Zhipeng
Hoogenraad, Nicholas Johannes
Scott, Andrew Mark
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-024-06836-1
- URN
-
urn:nbn:de:101:1-2410112115365.279819673812
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Burvenich, Ingrid Julienne Georgette
- Osellame, Laura Danielle
- Rigopoulos, Angela
- Huynh, Nhi
- Cao, Zhipeng
- Hoogenraad, Nicholas Johannes
- Scott, Andrew Mark
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis
Vascular promotion reprograms the tumour microenvironment toward enhanced drug delivery
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Activation of GPR81 by lactate drives tumour-induced cachexia
Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
Challenges in Targeting the “Crosstalks” in Cancer Cachexia
Retraction Note: Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
Targeting WDxR motif reprograms immune microenvironment and inhibits hepatocellular carcinoma progression
Cachexia
Cachexia
The potential of hyperpolarised 13C-MRI to target glycolytic tumour core in prostate cancer
Enhanced tumour cell nuclear targeting in a tumour progression model
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis
Vascular promotion reprograms the tumour microenvironment toward enhanced drug delivery
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Activation of GPR81 by lactate drives tumour-induced cachexia
Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
Challenges in Targeting the “Crosstalks” in Cancer Cachexia
Retraction Note: Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
Targeting WDxR motif reprograms immune microenvironment and inhibits hepatocellular carcinoma progression
Cachexia
Cachexia
The potential of hyperpolarised 13C-MRI to target glycolytic tumour core in prostate cancer
Enhanced tumour cell nuclear targeting in a tumour progression model
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis
Vascular promotion reprograms the tumour microenvironment toward enhanced drug delivery
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Activation of GPR81 by lactate drives tumour-induced cachexia
Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
Challenges in Targeting the “Crosstalks” in Cancer Cachexia
Retraction Note: Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
Targeting WDxR motif reprograms immune microenvironment and inhibits hepatocellular carcinoma progression
Cachexia
Cachexia
The potential of hyperpolarised 13C-MRI to target glycolytic tumour core in prostate cancer